Norris Medicines Balance Sheet Annual

BSE: 524414 | NSE: - | ISIN: INE744C01029 | Sector: Biotechnology & Drugs

18.47 -0.97 (-4.99%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.04	-	0.02	0.02
Short Term Investments	0.71	-	0.70	1.30
Cashand Short Term Investments	0.75	-	0.72	1.32
Accounts Receivable- Trade Net	1.06	-	1.09	1.79
Total Receivables Net	1.06	-	1.09	1.79
Total Inventory	4.33	-	2.42	5.10
Other Current Assets Total	0.00	-	0.04	0.02
Total Current Assets	6.14	-	4.27	8.23
Property/ Plant/ Equipment Total- Net	5.79	-	7.07	7.67
Long Term Investments	0.43	-	0.42	0.38
Note Receivable- Long Term	0.87	-	0.82	0.81
Other Long Term Assets Total	0.96	-	1.61	2.69
Total Assets	14.19	-	14.19	19.79
Accounts Payable	1.78	-	1.33	5.24
Notes Payable/ Short Term Debt	0.00	-	0.00	0.00
Other Currentliabilities Total	7.45	-	5.46	6.45
Total Current Liabilities	9.23	-	6.78	11.69
Long Term Debt	18.59	-	18.10	15.52
Total Long Term Debt	18.59	-	18.10	15.52
Total Debt	18.59	-	18.10	15.52
Deferred Income Tax	0.00	-	0.00	0.00
Other Liabilities Total	0.00	-	0.00	0.00
Total Liabilities	27.82	-	24.88	27.22
Common Stock Total	9.93	-	9.93	9.93
Retained Earnings( Accumulated Deficit)	-23.56	-	-20.62	-17.36
Total Equity	-13.63	-	-10.69	-7.43
Total Liabilities Shareholders' Equity	14.19	-	14.19	19.79
Total Common Shares Outstanding	1.00	-	1.00	1.00
Tangible Book Valueper Share Common Eq	-13.63	-	-10.69	-7.43